Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Atezolizumab Injection|DRUG: Ipatasertib|DRUG: Bevacizumab|DRUG: Pertuzumab|DRUG: Trastuzumab
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Collaborators: Hoffmann-La Roche